04.02.2013 Views

official journal of the patent office - Controller General of Patents ...

official journal of the patent office - Controller General of Patents ...

official journal of the patent office - Controller General of Patents ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(12) PATENT APPLICATION PUBLICATION<br />

(19) INDIA (21) Application No.: 1244/MUM/2004 A<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application: 18/11/2004 (43) Publication Date: 09/06/2006<br />

(54) Title <strong>of</strong> <strong>the</strong> invention: NOVEL FLOATING DOSAGE FORM<br />

(51) International classification : A61K9/24,<br />

A61K 9/00,<br />

A61K 9/00<br />

(31) Priority Document No : NIL<br />

(32) Priority Date : NIL<br />

(33) Name <strong>of</strong> priority country : NIL<br />

(86) International Application No : NIL<br />

and Filing Date : NIL<br />

(87) International Publication No : NIL<br />

(61) Patent <strong>of</strong> addition to :<br />

Application No<br />

NIL<br />

(62)<br />

Filed on : N.A.<br />

Divisional to Application No : 565/MUM/2002<br />

Filed on : 26/06/2002<br />

(71) Name <strong>of</strong> Applicant:<br />

CADILA HEALTHCARE LIMITED<br />

Address <strong>of</strong> <strong>the</strong> Applicant:<br />

ZYDUS TOWER, SATELITE CROSS<br />

ROADS, AHMEDABAD-380 015,<br />

INDIA.<br />

(72) Name <strong>of</strong> <strong>the</strong> Inventor:<br />

1. LOHRAY BRAJ B<br />

2. TIWARI SANDIP B<br />

3. PAI RAVEENDRA M<br />

4. KRISHNA MURTHY T<br />

5. METHTA PAVAK R<br />

Filed U/S 5(2) before The <strong>Patents</strong><br />

(Amendment) Act, 2005: NO<br />

(57) Abstract: A pharmaceutical gastro-retentive delivery system for controlled release <strong>of</strong> <strong>the</strong>rapeutically active<br />

agent in stomach or upper part <strong>of</strong> gastro-intestinal tract in <strong>the</strong> form <strong>of</strong> bilayer dosage form which comprises,<br />

One layer (layer-A) which is responsible for retaining <strong>the</strong> dosage form in stomach or upper part <strong>of</strong> gastro-intestinal<br />

tract (spatial control) for a prolonged period, comprising <strong>of</strong> pharmaceutical excipients having low bulk desity,<br />

optionally with o<strong>the</strong>r pharmaceutical aids.<br />

Second layer (Layer-B) which is responsible for prolonged or controlled drug delivery (temporal control) <strong>of</strong><br />

<strong>the</strong>rapeutic agent which comprises <strong>of</strong> <strong>the</strong> active agent and controlled release matrix polymers optionally with o<strong>the</strong>r<br />

pharmaceutical aids.<br />

Drawing Sheets: NIL<br />

Total Pages: 20.<br />

Fig. Nil<br />

The Patent Office Journal 09/06/2006 10911

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!